– USA, TX – Group1, the world’s first battery technology and materials company to commercialize potassium-ion batteries, announced the addition of Dr. Michael Bartholomeusz to its Board as an Independent Director.
About Dr. Michael Bartholomeusz
Dr. Bartholomeusz’s extensive experience and success in guiding technology companies through periods of accelerated growth make him a strong addition to Group1 as we continue to lead and redefine the battery sector and transition into the next phase of product introduction and growth.
Dr. Bartholomeusz brings a wealth of experience as a private and public company board director, and global CEO and executive. He has led companies in multiple industries including advanced materials, electronics, renewables, and battery technology; and has successfully managed corporate funding, acquisitions, joint ventures, and sales in regions including the U.S., Europe, China, and greater Asia.
About Group1
Group1 is the world’s first battery technology and materials company commercializing potassium-ion batteries. Our core technology, rooted in the labs of 2019 Nobel Laureate Professor JB Goodenough, is pushing the boundaries of energy storage. We enable the production of faster-charging, high-energy-density batteries that are free of critical minerals and compatible with existing lithium-ion battery manufacturing processes. KIBs are poised to meet the performance demands of electric vehicles, energy storage systems, and other applications currently reliant on lithium iron phosphate lithium-ion batteries. Group1’s mission is to accelerate the energy transition while enhancing domestic resilience in a practical and streamlined way.
For more information: https://group1.ai/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.